TreeFrog Therapeutics has raised $75 million in financing to support the clinical development of its stem cell-derived cell therapies…
Articles by Patricia Inácio, PhD
High prices, lack of access, and long waiting times are major barriers to people who want to undergo genetic testing…
The majority of Parkinson’s patients given Sunovion‘s Kynmobi (apomorphine hydrochloride) for “off” episodes during Phase 3 clinical trials…
A potential Parkinson’s therapy based on a protein with an ability to protect neurons — called recombinant (lab-made) human …
One in three people with early to mid-stage Parkinson’s disease were found to have difficulties in learning a new…
A non-invasive test that measures signals from the olfactory bulb — the part of the brain responsible for scent-perception —…
A medicine approved to treat attention deficit hyperactivity disorder (ADHD), called atomoxetine, could help to improve thinking and impulse control…
Telehealth, together with wearable sensors that accurately monitor symptoms like tremor, may help to improve quality of life for people…
Periodontitis, or gum disease, may increase the risk of Parkinson’s disease, according to a large population-based study conducted in…
A new technique allowed researchers to label with specificity proteins inside neurons of the striatum — a brain region involved…